companydata.dkcompanydata.dk

BIOSYNTIA ApS: Financial statements 2016

CVR: 34892970

Source: annual report 2016, Danish Business Authority

01/01/201631/12/2016

BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 619,242 and a net result of DKK -2,837,632 compared with DKK -1,682,434 the year before. That is a decrease of 46.5% compared with the year before. Equity in the 2016 report amounted to DKK 8,028,272. The solvency ratio was 79.2%. The company had 8 employees in the financial year.

Gross Profit
DKK 619,242
Profit/Loss
DKK -2,837,632
Equity
DKK 8,028,272
Total Assets
DKK 10,131,539
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-619 t.-2.8 mio.8 mio.8
2015-1.2 mio.-1.7 mio.3.9 mio.-
2014-1.6 mio.-4 t.48 t.-
2013-389 t.-28 t.52 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like BIOSYNTIA ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2016

BIOSYNTIA ApS appoints new auditorJul 4, 2016

As of July 4, 2016, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of BIOSYNTIA ApS.

Auditor steps down at BIOSYNTIA ApSJul 4, 2016

As of July 4, 2016, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of BIOSYNTIA ApS.

BIOSYNTIA ApS: The 2015 annual report is outJun 1, 2016

BIOSYNTIA ApS has published its annual report for 2015. Gross profit came to DKK 1,157,909, and the net result was DKK -1,682,434.

About BIOSYNTIA ApS

BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The board consists of Henrik Dalbøge (chair), Joško Bobanović and Thomas Grotkjær. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees (2018). In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity in the 2025 report amounted to DKK 32,860,576.

Source: annual report 2025, Danish Business Authority